The latest closing stock price for Neumora Therapeutics as of February 21, 2025 is 1.80.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-889 today, roughly -1 times their original investment - a -88.92% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 1066.7% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.60, which is 11.1% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 10.50.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-889 today, roughly -1 times their original investment - a -88.92% compound annual growth rate over 1 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 21.00, which is 1066.7% above the current share price.
The Neumora Therapeutics 52-week low stock price is 1.60, which is 11.1% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 10.50.